Newsroom

Press Release

NeoGenomics Reports 11% Revenue Growth to $106 Million in the First Quarter

NeoGenomics Provides COVID-19 Business Update

NeoGenomics Integrates HALO(R) From Indica Labs

NeoGenomics Schedules its First Quarter Earnings Release for April 28, 2020

NeoGenomics Announces Three-Year Contract to be Cornerstone Oncology and Cancer Testing Laboratory for Large, National Group Purchasing Organization

NeoGenomics To Present At 41st Annual Raymond James Institutional Investor Conference

NeoGenomics Reports 40% Revenue Growth to $107 Million in the Fourth Quarter

NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2019 Earnings Release for February 27, 2020

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients